Search results
We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.
- 40.69Add to watchlist+0.22 (+0.53%)As of Mon. Jun 24, 2024 10:24 AM EDT · Nasdaq Real Time Price (USD) · Market open
- Open40.80High40.84Low40.67
- Mkt Cap84.37BP/E (TTM)14.69Div & Yield1.50 & 3.72%
- Prev. Close40.4852 Wk. Low33.6752 Wk. High45.93
What analysts are sayingTop storiesTech Keeps a Lid on US Stocks as Nvidia Tumbles: Markets WrapYahoo Finance · 50 minutes agoGilead (GILD) Up as Twice-Yearly HIV Shot Prevents InfectionYahoo Finance · 3 days agoMyriad Genetics (MYGN) and GSK Unite to Boost HRD TestingYahoo Finance · 2 weeks agoRelated stocks
GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with global headquarters in London.
Home | GSK US. ERG in action. During Pride Month, we are shining the spotlight on our LGBTQ+ ERG, Spectrum. In 1996, a group of GSK staff formed the first Spectrum branch and they have not slowed down since. We now have active branches at each of our US locations. Read our article about Spectrum. Behind the science US edition.
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together.
Find the latest GSK plc (GSK) stock quote, history, news and other vital information to help you with your stock trading and investing.
From quarterly updates to key announcements, here you can access GSK investor-related information.
GSK has a significant footprint in the US across commercial, R&D, manufacturing, and corporate functions. We employ ~15,000 people across the US and have two corporate hubs. Explore GSK in the US.
Get the latest GSK plc (GSK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We prioritise innovation in vaccines and specialty medicines to prevent and treat disease. Download.
For detail see gsk.com – onsumer Healthcare capital markets day in February 2022 highlighted our strategic priorities, key C growth drivers and detailed financial information.